5th International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplant
The Fifth International Workshop on Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation and Cellular Therapy (HSCT²) will gather the leaders in the field to update us on these issues as well as novel mechanisms of relapse that have recently been described and discovered. As a workshop participant, you will benefit from the knowledge of internationally recognized speakers from a diverse multidisciplinary group comprised of basic and translational scientists and clinical investigators. Tremendous progress in treatment research has been made over the recent past years, and we are eager to share it with you.
The Fifth International Workshop on Biology, Prevention and Treatment of Relapse After Hematopoietic Stem Cell Transplantation and Cellular Therapy (HSCT²) will take place at the first-class, centrally located Grand Hyatt New York in Midtown Manhattan. The Organizing Committee is working diligently to make this Fifth International Workshop a truly valuable experience for all participants. We look forward to learning alongside you and welcoming you to the vibrant, captivating city of New York.
- Explain the mechanisms and optimal drug dosing of radio-chemo resistance including new regimens;
- Compare immune escape between leukemia and myeloma, including optimal donor selection and graft source;
- Analyze how the IMPACT FIGARO trial can be applied to individual practice;
- Discuss the variables and considerations in selecting optimal cells for immunotherapy;
- Explain strategies to prevent resistance to CAR T-cell exhaustion following relapse for myeloid malignancies and utilize checkpoint blockade to enhance CAR T-cell function;
- Discuss challenges in study designs for relapse prevention in the pursuit of creating improved targeted treatment regimens;
- Describe the mechanisms of relapse microbiota of T-cell trafficking and immune reconstitution;
- Compare how new off-the-shelf cell therapy products affect patients;
- Explain the difference in treatment of relapse between myeloma, lymphoma, myeloid leukemia, and relapse post-CAR.
Agenda subject to change.
Discover an urban retreat in the heart of Midtown NYC at Sheraton New York Times Square Hotel. This hotel offers intuitively designed guest rooms, where perks like high-speed Wi-Fi, luxurious bedding and deluxe amenities await. Break a sweat in the 4,000-square-foot, state-of-the-art fitness center or dine on delicious market-inspired cuisine at Hudson Market, the signature hotel restaurant. Sip on cocktails or Starbucks® coffees at the sophisticated Library Bar, and work productively in the on-site business center.
New York City, known as "the City that Never Sleeps," offers year-round entertainment at all hours of the day, and this Midtown location puts guests right where they need to be. With world-famous shops, restaurants, and museums on your doorstep, the Sheraton New York Times Square is the perfect home base for your NYC adventure.
To learn more about accommodations, visit the conference website below!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Sara Baratta at 630-776-3934 or via email at HSCTconference@mocandco.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Professor of Medicine
Director, Hematopoietic Stem Cell Transplantation Program
University of Chicago
Alan Wayne, MD
Director, Cancer and Blood Disease Institute
Head, Division of Hematology-Oncology
Attending Physician, Hematology-Oncology
Alfred E. Mann Family Foundation Chair in Cancer Research
Professor of Pediatrics and Medicine
University of Southern California
Deputy Division Head, Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Nicolaus Kröger, MD
Director, Department of Stem Cell Transplantation
University Hospital Hamburg
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and the Organizing Committee. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). International physicians interested in converting AMA PRA Category 1 Credit™ to EACCME credit should contact the UEMS.
VIRTUAL EXHIBIT OPPORTUNITIES AVAILABLE!
Registration is now open! Click the button below to get started.
Physicians & Scientists
Other Healthcare Professionals
After creating an account or logging in, enter the access code to unlock the credit claiming process.